Posters, Presentations & Publications
For Presentations and Posters in PDF Adobe Acrobat Reader is required. If you experience problems downloading the PDF, see Note in right margin, or we can send an 11x17 hard copy to you. Please e-mail info@inspirepharm.com with name, address, &  telephone number.

2008  2007  2006  2005  2004  2003  2002  2001  2000  1996-1999

Kellerman D, Rossi Mospan A, Engels J, Schaberg A, Gorden J, Smiley L. Denufosol: A review of studies with inhaled P2Y2 agonists that led to Phase 3. Pulm Pharmacol Ther. 2007 December 31.

Ratner PH, Amar NJ, Hampel FC, van Bavel JH, Widmann MC, Kellerman D, Tian W, Schaberg A. Epinastine HCl nasal spray is effective and well tolerated for the treatment of seasonal allergic rhinitis. PowerPoint presentation at The 2007 Annual Meeting of American College of Allergy, Asthma, & Immunology (ACAAI). 2007 November 8-14; Dallas, Texas, USA. Abstract in PDF

LaVange L, Engels J, Accurso FJ. Analyzing percent change in cystic fibrosis clinical trials. Poster presented at The 21st Annual North American Cystic Fibrosis Conference. 2007 October 3-6; Anaheim, California, USA. Poster in PDF

Mathews D, Schaberg A, Brandi V, Engels J, Gorden J, Deterding R. Pediatric experience from three integrated phase 2 studies of denufosol tetrasodium inhalation solution. Poster presented at The 21st Annual North American Cystic Fibrosis Conference. 2007 October 3-6; Anaheim, California, USA. Poster in PDF

Friedman JY, Hardy C, Dewitt EM, Schulman KA, Reed SD. Patterns of antibiotic use for patients with mild cystic fibrosis. Poster presented at The 21st Annual North American Cystic Fibrosis Conference. 2007 October 3-6; Anaheim, California, USA. Poster in PDF

Thelin W, Lazarowski E, Boyer JL, Boucher R. Denufosol is a stable and potent inducer of airway secretion. Poster presented at The 21st Annual North American Cystic Fibrosis Conference. 2007 October 3-6; Anaheim, California, USA. Poster in PDF

Johnson FL, Boyer JL, Leese PT, Crean C, Krishnamoorthy R, Durham T, Fox AW, Kellerman DJ.
Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589. Platelets. 2007 August;18(5):346-356.

Deterding RR, Lavange LM, Engels JM, Mathews DW, Coquillette SJ, Brody AS, Millard SP, Ramsey BW; for the Cystic Fibrosis Therapeutics Development Network and the Inspire 08-103 Working Group. Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis. Am J Respir Crit Care Med. 2007 August 15;176(4):362-369.

Watson PS, She J, Lampe JW, Polianski AB. The total systhesis of latrunculin B. Poster presented at The Gordon Research Confrence on Natural Products. 2007 July 22-27; Tilton, New Hampsire, USA.

Nichols K, Morris S, Tian W. An evaluation of the effects of epinastine HCl ophthalmic solution, 0.05% (Elestat®) on contact lens comfort in subjects with contact lens intolerance during allergy season. Poster presented at the 110th Annual American Optometric Association (AOA) Congress Optometry's Meeting. 2007 June 27-July 1; Boston, Massachusetts, USA.

Kellerman D, Warren S, Rossi A, Taylor G, Smiley L. Deposition and pharmacokinetic studies with inhaled P2Y2 agonists - Evidence of high lung delivery and minimal systemic exposure. Poster presented at the 30th European Cystic Fibrosis Society (ECFS) Conference. 2007 June 13-16; Belek, Turkey. Poster in PDF

Rossi A, Brandi V, Engels J, Gorden J, Schaberg A, Smiley L. Reactive airway disease and cystic fibrosis: A retrospective analysis of the safety and tolerability with denufosol inhalation solution. Poster presented at the 30th European Cystic Fibrosis Society (ECFS) Conference. 2007 June 13-16; Belek, Turkey. Poster in PDF

Wolff SC, Brubaker K, Navratil T, Fulcher EH, Lankford JR, Boyer JL. Evaluation of muscarinic receptor antagonism by antihistamines. Poster presented at the XXVI European Academy of Allergology and Clinical Immunology (EAACI) Congress. 2007 June 9-13; Göteborg, Sweden. Poster in PDF

Lukat K-F, Kuna P, Sanquer F, Ivan P, Dimitrov V, Molina Gorina M, Van De Heyning PH, Loureiro AC, the Bilastine International Working Group, Valiente R, Sologuren A. Treatment with Bilastine improves symptoms in patients with seasonal allergic rhinitis. Poster presented at the XXVI European Academy of Allergology and Clinical Immunology (EAACI) Congress. 2007 June 9-13; Göteborg, Sweden. Poster in PDF

Kuna P, Nowacki Z, Van Cauwenberghe P, Lukat KF, Spicakova M, Agache I, Fouquert L, Roger A, the Bilastine International Working Group, Sologuren A, Valiente R. A phase 3 study comparing the efficacy and safety of once daily Bilastine with cetirizine and placebo
for the treatment of Seasonal Allergic Rhinitis (SAR).
Poster presented at the XXVI European Academy of Allergology and Clinical Immunology (EAACI) Congress. 2007 June 9-13; Göteborg, Sweden. Poster in PDF

Brazzell R, Kellerman DJ, Schaberg A, Yerxa B,Durham T. Effect of diquafosol on ocular surface health in dry eye disease. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA. Poster in PDF

Ousler GW III, Brazzell K, Durham T, Walker P, Anderson RT, Abelson MB. A correlation between central corneal staining and visual function in patients diagnosed with dry eye. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA. Poster in PDF

Wolff SC, Brubaker K, Wright RC, Boyer JL. The pharmacological properties of epinastine on histamine H2 and H4 receptors. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA.

Bowman LM, Si E, Pang J, Friedlaender M. Development of a commercial eye drop formulation of azithromycin. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA. Poster in PDF

Yates KA, Romanowski EG, Kowalski RP, Mah FS, Gordon YJ. Frequent dosing with topical 1% azithromycin is effective in reducing azithromycin-resistant pseudomonas aeruginosa colony counts in a NZW rabbit model. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA. Poster in PDF

Cowlen M, Crean C, Poulin D, Ching S, Peterson W, Anderson S. 52-Week inhalation toxicology study of nebulized denufosol tetrasodium in Beagle dogs. Poster presented at the Society of Toxicology (SOT) 46th Annual Meeting. 2007 March 25-29; Charlotte, North Carolina, USA. Poster in PDF

Anderson S, Crean C, Poulin D, Ching S, Peterson W, Cowlen M. 26-Week inhalation toxicology study of nebulized denufosol tetrasodium in Sprague Dawley rats. Poster presented at the Society of Toxicology (SOT) 46th Annual Meeting. 2007 March 25-29; Charlotte, North Carolina, USA. Poster in PDF

Wolff SC, Brubaker K, Navratil T, Fulcher EH, Lankford JR and Boyer JL. Anticholinergic effects of antihistamine drugs used in the clinic. PowerPoint presentation at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2007 Annual Meeting. 2007 February 23-27; San Diego, California, USA. Presentation in PDF

 

 

 

Page last updated: 23-Jun-2008


Click here to download Acrobat Reader

Copyright © 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved

 







 

Note: If you are having problems opening any of the Posters or Presentations in PDF, please refresh your page to clear out the attempt and then, with your mouse hovering over the link to the PDF document, right click and choose Save Target As, choose a location on your hard drive to save the document and click save. Once the download is complete you will be given a choice to Open, Open Folder or Close. Click Open and the PDF should open immediately. If you continue to have problems, please conact info@inspirepharm.com.